Integer Stock (NYSE:ITGR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$91.38

52W Range

$62.00 - $123.78

50D Avg

$88.92

200D Avg

$85.82

Market Cap

$3.16B

Avg Vol (3M)

$501.92K

Beta

0.65

Div Yield

-

ITGR Company Profile


Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

11,000

IPO Date

Sep 29, 2000

Website

ITGR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Cardiac Rhythm Management & Neuromodulation$668.80M$660.61M-
Other Markets$77.75M$106.41M-
Cardio And Vascular$1.11B$949.58M-
Medical Segment--$1.55B
Non-Medical Segment--$43.33M

Fiscal year ends in Dec 25 | Currency in USD

ITGR Financial Summary


Dec 25Dec 24Dec 23
Revenue$1.85B$1.72B$1.56B
Operating Income$239.62M$208.24M$163.32M
Net Income$102.81M$119.90M$90.65M
EBITDA$370.29M$332.94M$275.71M
Basic EPS$2.96$3.60$2.72
Diluted EPS$2.89$3.40$2.69

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26Apr 30, 26 | 12:00 AM
Q4 25Feb 19, 26 | 12:00 AM
Q3 25Oct 23, 25 | 9:00 AM

Peer Comparison


TickerCompany
INSPInspire Medical Systems, Inc.
RXRXRecursion Pharmaceuticals, Inc.
PRCTPROCEPT BioRobotics Corporation
AORTArtivion, Inc.
HAEHaemonetics Corporation
ADUSAddus HomeCare Corporation
LIVNLivaNova PLC
UFPTUFP Technologies, Inc.
CONConcentra Group Holdings Parent, Inc.